From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Mortality Risk Following Osteoporotic Fracture

Elevated risk was associated with even minor fractures and, with hip fractures, persisted for at least 10 years.

Osteoporotic fractures, particularly of the hip and spine, are associated with premature mortality. To evaluate the extent of this risk, researchers followed 4005 older community-dwelling Australians (age, ≥60 at enrollment in 1989). During the next 18 years, 1295 participants (952 women, 343 men) experienced fractures of any type, most commonly involving the hip, vertebrae, pelvis, femur, or multiple ribs.

The mortality rate for participants with fractures was roughly double that of participants without fractures; relative mortality rose further after subsequent fractures (doubled for women, tripled for men). Elevated mortality risk continued for 5 years after fractures, persisting for 5 to 10 years in patients with hip fractures. In a detailed study of a subset of patients with fractures, the main clinical factors associated with excess mortality were older age, subsequent fracture, weak quadriceps strength, smoking (in women), and low physical activity (in men). No association was noted for chronic disease comorbidity.

Comment: These results demonstrate that, not only is osteoporotic fracture associated with excess mortality, but that this risk persists for several years after any fracture and as long as 10 years after hip fracture. In addition, excess risk occurs regardless of the location or severity of fracture and seems to be present regardless of chronic disease burden.

Thomas L. Schwenk, MD

Published in Journal Watch General Medicine February 5, 2009

Citation(s):

Bliuc D et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 2009 Feb 4; 301:513.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.